ATE95063T1 - Kalzitonin enthaltende emulsion zur nasalen verabreichung. - Google Patents

Kalzitonin enthaltende emulsion zur nasalen verabreichung.

Info

Publication number
ATE95063T1
ATE95063T1 AT91402231T AT91402231T ATE95063T1 AT E95063 T1 ATE95063 T1 AT E95063T1 AT 91402231 T AT91402231 T AT 91402231T AT 91402231 T AT91402231 T AT 91402231T AT E95063 T1 ATE95063 T1 AT E95063T1
Authority
AT
Austria
Prior art keywords
nasal administration
calcitonin
emulsion containing
containing calcitonin
preparations
Prior art date
Application number
AT91402231T
Other languages
English (en)
Inventor
Nakayuki Yamamoto
Michihiko Sugimoto
Hideo Sakakibara
Masaru Saita
Yuji Shimozono
Takafumi Manako
Original Assignee
Asahi Chemical Ind
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind, Hisamitsu Pharmaceutical Co filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE95063T1 publication Critical patent/ATE95063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT91402231T 1990-08-16 1991-08-12 Kalzitonin enthaltende emulsion zur nasalen verabreichung. ATE95063T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2215044A JPH078806B2 (ja) 1990-08-16 1990-08-16 カルシトニン類含有経鼻投与用乳剤

Publications (1)

Publication Number Publication Date
ATE95063T1 true ATE95063T1 (de) 1993-10-15

Family

ID=16665828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91402231T ATE95063T1 (de) 1990-08-16 1991-08-12 Kalzitonin enthaltende emulsion zur nasalen verabreichung.

Country Status (13)

Country Link
US (1) US5281580A (de)
EP (1) EP0471618B1 (de)
JP (1) JPH078806B2 (de)
KR (1) KR950000770B1 (de)
AT (1) ATE95063T1 (de)
AU (1) AU629758B2 (de)
CA (1) CA2047903C (de)
DE (1) DE69100436T2 (de)
DK (1) DK0471618T3 (de)
ES (1) ES2060329T3 (de)
IE (1) IE65630B1 (de)
NZ (1) NZ239166A (de)
PT (1) PT98692B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
IT1251685B (it) * 1991-10-11 1995-05-19 Isf Spa Composizioni farmaceutiche contenenti una calcitonina
US5948825A (en) * 1993-04-19 1999-09-07 Institute For Advanced Skin Research Inc. Microemulsion preparation containing a slightly absorbable substance
EP0726075A1 (de) * 1995-02-08 1996-08-14 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
WO2008007214A2 (en) * 2006-07-07 2008-01-17 Avestha Gengraine Technologies Pvt. Ltd. Glycyrrhiza glabra plant extracts for treating osteoporosis and the extraction process thereof
ES2394525T3 (es) 2006-09-27 2013-02-01 Asahi Kasei Pharma Corporation Calcitoninas para la prevención de la aparición de la distrofia simpática refleja tras un accidente cerebrovascular
KR101686271B1 (ko) 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 인간 변형성 슬관절증의 예방제 및/또는 치료제 및/또는 악화 억제제
US20190210394A1 (en) * 2018-01-05 2019-07-11 Beatrice A. Darby Reading staff book system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2212062A (en) * 1938-04-16 1940-08-20 Harry O Duerr Waste destructor and garbage reclamation unit
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4690852A (en) * 1985-06-11 1987-09-01 Paul Gach Foil for stained glass assembly
EP0234745B1 (de) * 1986-01-29 1991-06-12 Dyson Refractories Limited Katalysatoren
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH0669956B2 (ja) * 1988-09-30 1994-09-07 旭化成工業株式会社 ポリペプタイド類の吸着防止剤

Also Published As

Publication number Publication date
US5281580A (en) 1994-01-25
DE69100436D1 (de) 1993-11-04
EP0471618A1 (de) 1992-02-19
JPH0499729A (ja) 1992-03-31
KR920003991A (ko) 1992-03-27
NZ239166A (en) 1992-11-25
IE65630B1 (en) 1995-11-01
EP0471618B1 (de) 1993-09-29
KR950000770B1 (ko) 1995-02-02
DE69100436T2 (de) 1994-01-20
IE912614A1 (en) 1992-02-26
PT98692B (pt) 1999-01-29
DK0471618T3 (da) 1993-11-29
JPH078806B2 (ja) 1995-02-01
CA2047903A1 (en) 1992-02-17
AU629758B2 (en) 1992-10-08
AU8244591A (en) 1992-02-20
PT98692A (pt) 1992-07-31
CA2047903C (en) 1995-12-05
ES2060329T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
DE69100436T2 (de) Kalzitonin enthaltende Emulsion zur nasalen Verabreichung.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
DK358384A (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
DK0552256T3 (da) Fremgangsmåde til at behandle eller forebygge type 1 diabetes ved peroral indgivelse af insulin
BR9408343A (pt) Derivados 5-(2-imidazolinil amino) benzimidazol sua preparação e seu uso como agonistas alfa-2 adrenoceptor
KR890003369A (ko) 약제학적 제제
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
MY102565A (en) Novel derivatives of guanine
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
ZA874812B (en) Drug
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
DE69226370T2 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
DK0490549T3 (da) Stabilisering af calcitonin-holdige farmaceutiske præparater
DE69122364T2 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
ATE284697T1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
AU555818B2 (en) Amino hydroxy proprophenones pharmaceutical use
EA199900226A1 (ru) Фармацевтические композиции для лечения вирусных заболеваний
KR900701278A (ko) 바이러스 감염 치료용 담즙산
KR880004810A (ko) 소화성 궤양 치료제
SE8204670L (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
KR900014308A (ko) 비스펜에탄올아민
PT93597A (pt) Processo para a preparacao de derivados cefalosporanicos polares e de composicoes farmaceuticas que os contem
HK1005063A1 (en) Pharmaceutical compositions containing 1- oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes
DE69113675T2 (de) Verwendung von Naproxen als Mydriatikum.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee